Criminal Investigation for Excess Deaths Due to Remdesivir
The antiviral drug remdesivir, brand name Veklury, is approved for use against COVID-19
despite research showing it lacks effectiveness and can cause high rates of organ failure
John Beaudoin is calling for a criminal investigation into remdesivir, citing data that it
may have killed 100,000 people in the U.S.
Beaudoin received all the death certificates in Massachusetts from 2015 to 2022, finding 1,840 excess deaths from acute renal failure from January 1, 2021, to November 30,
2022, which he believes may be due to remdesivir
A study published in The Lancet found “no clinical benefit" from the use of remdesivir in
hospitalized patients
The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when
remdesivir is used
despite research showing it lacks effectiveness and can cause high rates of organ failure
John Beaudoin is calling for a criminal investigation into remdesivir, citing data that it
may have killed 100,000 people in the U.S.
Beaudoin received all the death certificates in Massachusetts from 2015 to 2022, finding 1,840 excess deaths from acute renal failure from January 1, 2021, to November 30,
2022, which he believes may be due to remdesivir
A study published in The Lancet found “no clinical benefit" from the use of remdesivir in
hospitalized patients
The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when
remdesivir is used
Just like mRNA , it Remdisavir has failed all efficacy tests and horrid safety profile it is very deadly. Plus the approval for its use is by the people who make it and who soon will work for who makes it. Zero trust for them , be proactive with your healthcare , only trust your own research. The last 3 years have clearly shown how deadly undeserving trust can be.